Epstein, S. E., Levin, S., Onomichi, K., Langston, C., Yeshokumar, A., Fabian, M., Sand, I. K., Klineova, S., Lublin, F., Dykstra, K., Xia, Z., De Jager, P., Levine, L., Farber, R., Riley, C., & Vargas, W. S. (2021). Myelin oligodendrocyte glycoprotein (MOG) antibody-mediated disease: The difficulty of predicting relapses. Multiple Sclerosis and Related Disorders, 56, 103229. https://doi.org/10.1016/j.msard.2021.103229